Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Clavis/Clovis' Pancreatic Cancer Drug Fails Despite Personalized Medicine Approach

12 Nov 2012

• By John Davis

Related Content

Clovis Taps Into Rich "A" Round, Grabs Licensing Rights to Improved Gemcitabine

24 Nov 2009

Clovis And Clavis' Gemcitabine Derivative Partnership Goes From Regional To Worldwide

11 Nov 2010

Related Companies

AqualisBraemar ASA

Clovis Oncology, Inc.

Eli Lilly and Company

Additional Topics

Norway Europe Clinical Trials BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.